Nurse Practitioner in Oceanport, NJ Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Ms. Rebecca Florence Mizrahi, APN Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1075 Stephenson Ave, Oceanport, NJ 07757 Phone: 848-208-2636 |
Sharisa Lovick, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1075 Stephenson Ave, Oceanport, NJ 07757 Phone: 732-592-3400 |
Jenna R. Sabatino, APN Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 1075 Stephenson Ave, Oceanport, NJ 07757 Phone: 732-904-0966 |
News Archive
Unvaccinated children 23 times more likely to get infected with whooping cough
Children of parents who refuse vaccines are 23 times more likely to get whooping cough compared to fully immunized children, according to a new study led by a vaccine research team at Kaiser Permanente Colorado's Institute for Health Research.
New research examines antibiotic choice for treating children with community-acquired pneumonia
New Vanderbilt-led research shows hospitals are doing a better job of using antibiotics less commonly associated with antibiotic resistance to treat children hospitalized with community-acquired pneumonia (CAP).
CureVac collaborates with Janssen on development of influenza vaccine based on mRNA
CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.
HIV Collaborative Fund receives $5.2 million from the Bill & Melinda Gates Foundation
The HIV Collaborative Fund, a partnership of the International Treatment Preparedness Coalition and Tides, announced today that it has received a three-year grant for $5.2 million from the Bill & Melinda Gates Foundation to support community-based organizations in sub-Saharan Africa engaged in advocacy and educational activities to increase access to HIV treatment and prevention services.
New treatment option for postmenopausal women with non-invasive breast cancer
Anastrozole provides a significant benefit compared with tamoxifen in preventing recurrence after a lumpectomy and radiation therapy in postmenopausal women ages 60 years or younger who had DCIS (ductal carcinoma in situ), a common diagnosis of non-invasive breast cancer. In women over age 60, it works as well as tamoxifen.
› Verified 1 days ago